Deferred Tax Assets, Valuation Allowance of Bone Biologics Corp from 31 Dec 2013 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Bone Biologics Corp quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2013 to 31 Dec 2025.
  • Bone Biologics Corp Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $24,811,000, a 14% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Bone Biologics Corp Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $24,811,000 +$3,129,000 +14% 31 Dec 2025 10-K 02 Mar 2026 2025 FY
Q4 2024 $21,682,000 +$1,271,000 +6.2% 31 Dec 2024 10-K 02 Mar 2026 2025 FY
Q4 2023 $20,411,000 +$59,000 +0.29% 31 Dec 2023 10-K 26 Feb 2025 2024 FY
Q4 2022 $20,352,000 +$1,559,000 +8.3% 31 Dec 2022 10-K 21 Feb 2024 2023 FY
Q4 2021 $18,793,000 +$445,000 +2.4% 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q4 2020 $18,348,000 +$528,000 +3% 31 Dec 2020 10-K 15 Mar 2022 2021 FY
Q4 2019 $17,820,000 +$943,000 +5.6% 31 Dec 2019 10-K 15 Apr 2021 2020 FY
Q4 2018 $16,877,000 +$958,000 +6% 31 Dec 2018 10-K 30 Mar 2020 2019 FY
Q4 2017 $15,919,000 +$36,056,000 31 Dec 2017 10-K 29 Mar 2019 2018 FY
Q4 2016 $20,137,000 -$29,691,000 -311% 31 Dec 2016 10-K 02 Apr 2018 2017 FY
Q4 2015 $9,554,000 +$4,795,000 +101% 31 Dec 2015 10-K 30 Mar 2017 2016 FY
Q4 2014 $4,759,000 +$1,681,000 +55% 31 Dec 2014 10-K 28 Mar 2016 2015 FY
Q4 2013 $3,078,000 31 Dec 2013 10-K 31 Mar 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.